Prucalopride in Patients With Chronic Idiopathic Constipation
Status:
Completed
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the
treatment of chronic idiopathic constipation.
Hypothesis:
Prucalopride given at a dose of 1 mg o.d. for 4 weeks to female patients with chronic
constipation shows a favourable effect on most of the efficacy parameters assessed in this
trial. This dosage can be considered safe and generally well-tolerated.